BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 23, 2009
 |  BioCentury  |  Product Development

Pipeline proliferation

Pipeline proliferation

Growth regulation Angiogenesis Apoptosis
AMG 102 AMG 479 Vectibix panitumumab (B) AMG 386 Motesanib (AMG 706)(C) rhApo2L/TRAIL (D) AMG 655
Human mAb against hepatocyte growth factor/ scatter factor (HGF/SF) Human mAb against insulin-like growth factor-1 (IGF-1) receptor Human mAb against EGFR 1...

Read the full 300 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >